Baldwin Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,975
Closed -$204 253
2021
Q4
$204 Sell
1,975
-575
-23% -$66.6K 0.03% 247
2021
Q3
$320K Hold
2,550
0.06% 195
2021
Q2
$317K Sell
2,550
-50
-2% -$6.28K 0.05% 201
2021
Q1
$307K Sell
2,600
-130
-5% -$15.2K 0.06% 204
2020
Q4
$320K Buy
+2,730
New +$301K 0.06% 178

Other funds holding MDT

Baldwin Investment Management's MDT Position: Q1 2022 in Review

Baldwin Investment Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 1,975 shares — an estimated $204 sold.

Baldwin Investment Management first reported a position in MDT in Q4 2020 and held it in 5 quarters. The position peaked at $320K in Q3 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Baldwin Investment Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Baldwin Investment Management sold 1,975 Medtronic shares in Q1 2022, an estimated $204.
  • Baldwin Investment Management first reported a position in Medtronic in Q4 2020 and held it in 5 quarters.
  • Baldwin Investment Management's Medtronic position peaked at $320K in Q3 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Baldwin Investment Management's 13F filing for Q1 2022, filed 16 May 2022.